Affiliation:
1. Department of Neuroscience, Head and Neck—Neurology Unit Vito Fazzi Hospital, ASL Lecce Lecce Italy
Abstract
AbstractA patient with chronic migraine and generalized myasthenia gravis was concurrently treated with fremanezumab and with therapeutic plasmapheresis (PEX). Fremanezumab was dosed right after a PEX session, or in the midpoint between sessions, and the efficacy of both treatments was maintained. This case broadens the drug's clinical applications and it helps in choosing the appropriate medical regimen in patients requiring both treatments.
Subject
Neurology (clinical),Neurology